Approval · Notice of Compliance 5075 · 1995
GEN-INDAPAMIDE: Notice of Compliance 5075
Issued February 15, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5075
- Date
- February 15, 1995
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Diuretic, antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-INDAPAMIDE | 02153483 | Marketed |
Medicinal ingredients
- INDAPAMIDE HEMIHYDRATE 2.5 MG per TAB